Pilot Projects Program

试点项目计划

• 批准号: 10458567
• 负责人: Kevin Joseph Pearson
• 金额: $ 22.95万
• 依托单位: UNIVERSITY OF KENTUCKY
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-08-01 至 2024-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10458567
• 关键词: Advisory Committees; Appalachian Region; Applications Grants; Area; Biomedical Research; Cardiovascular Diseases; Categories; Centers of Research Excellence; Clinical Sciences; Clinical and Translational Science Awards; Consultations; Core Facility; Data; Development; Diabetes Mellitus; Disease; Extramural Activities; Floor; Funding; Funding Opportunities; Generations; Goals; Grant; Head; Health; Infrastructure; Institution; Kentucky; Link; Malignant Neoplasms; Mentors; Modernization; Names; Nerve Degeneration; Neurodegenerative Disorders; Non-Insulin-Dependent Diabetes Mellitus; Obesity; Outcome; Peer Review; Phase; Pilot Projects; Process; Program Research Project Grants; Publications; Research; Research Personnel; Research Support; Resources; Risk Factors; Secure; Services; Standardization; Substance abuse problem; Talents; Translational Research; United States National Institutes of Health; Universities; base; biomedical facility; cancer type; clinical center; design; driving force; experience; health disparity; human disease; member; multidisciplinary; operation; programs; recruit; success; translational study

The primary objective of the Phase III Pilot Project Program of the COCVD is to build upon and expand momentum by providing short-term funding for meritorious pilot studies that focus on obesity as a risk factor for human diseases. Working in parallel with identified areas of biomedical research strength at our institution, the program will emphasize support for pilot projects that examine the relationship between obesity and cardiovascular diseases, type 2 diabetes, cancer and neurodegenerative diseases. The Program will support studies for junior/new investigators to study obesity as a risk factor for human diseases, established investigators who include obesity as a risk factor within their area of disease specialization, and multidisciplinary teams of investigators for submission of programmatic grant applications. Decisions on support will follow NIH-format review by members of the COCVD during Phase I and II of the program, supplemented by members with specific expertise (e.g., cancer). Initial scientific merit reviews will be submitted to the Internal Scientific Advisory Committee for initial ranking determinations, followed by the External Advisory Committee for their review and input. Pilot Project grants are designed for 1 year ($50,000) with a second year contingent upon progress. The successes of the program to date in operation and function will carry into Phase III of the COCVD.

COCVD第三阶段试点项目计划的主要目标是建立和扩大 通过提供短期资金，为有价值的试点研究提供动力，重点关注肥胖作为一个危险因素， 人类疾病。与我们机构确定的生物医学研究实力领域平行工作， 该计划将强调对试点项目的支持，这些项目将研究肥胖与肥胖之间的关系。 心血管疾病、2型糖尿病、癌症和神经退行性疾病。该计划将支持 为初级/新研究人员研究肥胖作为人类疾病的危险因素， 将肥胖作为危险因素纳入其疾病专业领域的研究者，以及 多学科调查小组，以提交方案赠款申请。决定 在项目的第一阶段和第二阶段，支持将遵循COCVD成员对NIH格式的审查， 由具有特定专长的成员补充（例如，癌症）。初步的科学价值审查将 提交给内部科学咨询委员会进行初步排名确定，然后是 外部咨询委员会的审查和意见。试点项目赠款设计为1年（50，000美元） 第二年视进展而定。该方案迄今在运作和运作方面取得的成功 将进入COCVD的第三阶段。